Search
for
Sort by
Research 661–690 of 1000+
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- A Theoretical Model for the Treatment of Androgenetic Alopecia Using the STEAP3 Protein, and the Genetic Challenges of Treating AGA
- Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
- Next Generation Therapeutics for Androgenetic Alopecia
- Efficient Silencing of Androgen Receptor Gene via UTR-Targeting siRNAs for Androgenetic Alopecia Therapy
- Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
- 0885 The androgen-THY1 axis mediates sexual dimorphism in dermal adipogenesis and fibrosis
- Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men
- 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA)
- Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men
- Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- The Association of Gene Expression and Single Nucleotide Polymorphism (rs 6152 SNP) in Androgen Receptor Gene with Recurrent Spontaneous Abortion (RSA) in Iraqi Women
- 우슬의 에탄올 추출물이 모발 성장에 미치는 영향
- A review of genetic researches of and rogenic alopecia
- Sexual steroid regulation of spermatogenesis: new actors enter the stage
- Modelling androgen synthesis and action during human sexual differentiation
- Non-competitive androgen receptor inhibition in vitro and in vivo
- Structural Characterization and Ligand Specific Protein Interactions of Androgen Receptor
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- 1343 Efficacy of asymmetric siRNA targeting androgen receptor for the treatment of androgenetic alopecia
- 1494 Dual effects of HA-iMSC-exosomes in human follicle dermal papilla cells (HFDPC) on androgenic alopecia in vitro model
- Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology
- Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia
- 746 Transcriptomic profiling of frontal and occipital dermal papilla reveals potential role of TRPS1 in androgenic alopecia